Literature DB >> 34964641

Exploring the pH- and Ligand-Dependent Flap Dynamics of Malarial Plasmepsin II.

Jack A Henderson1, Jana Shen1.   

Abstract

Malaria remains a global health threat─over 400,000 deaths occurred in 2019. Plasmepsins are promising targets of antimalarial therapeutics; however, no inhibitors have reached the clinic. To fuel the progress, a detailed understanding of the pH- and ligand-dependent conformational dynamics of plasmepsins is needed. Here we present the continuous constant pH molecular dynamics study of the prototypical plasmepsin II and its complexed form with a substrate analogue. The simulations revealed that the catalytic dyads D34 and D214 are highly coupled in the apo protein and that the pepstatin binding enhances the difference in proton affinity, making D34 the general base and D214 the general acid. The simulations showed that the flap adopts an open state regardless of pH; however, upon pepstatin binding the flap can close or open depending on the protonation state of D214. These and other data are discussed and compared with the off-targets human cathepsin D and renin. This study lays the groundwork for a systematic investigation of pH- and ligand-modulated dynamics of the entire family of plasmepsins to help design more potent and selective inhibitors.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34964641      PMCID: PMC8812262          DOI: 10.1021/acs.jcim.1c01180

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  41 in total

1.  Improved treatment of the protein backbone in empirical force fields.

Authors:  Alexander D MacKerell; Michael Feig; Charles L Brooks
Journal:  J Am Chem Soc       Date:  2004-01-28       Impact factor: 15.419

Review 2.  Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases.

Authors:  Raitis Bobrovs; Kristaps Jaudzems; Aigars Jirgensons
Journal:  J Med Chem       Date:  2019-05-16       Impact factor: 7.446

3.  Flap dynamics of plasmepsin proteases: insight into proposed parameters and molecular dynamics.

Authors:  Wilson Karubiu; Soumendranath Bhakat; Lara McGillewie; Mahmoud E S Soliman
Journal:  Mol Biosyst       Date:  2015-04

4.  Proton-Coupled Conformational Allostery Modulates the Inhibitor Selectivity for β-Secretase.

Authors:  Robert C Harris; Cheng-Chieh Tsai; Christopher R Ellis; Jana Shen
Journal:  J Phys Chem Lett       Date:  2017-09-21       Impact factor: 6.475

5.  Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.

Authors:  A M Silva; A Y Lee; S V Gulnik; P Maier; J Collins; T N Bhat; P J Collins; R E Cachau; K E Luker; I Y Gluzman; S E Francis; A Oksman; D E Goldberg; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

6.  Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from plasmodium falciparum.

Authors:  N K Bernstein; M M Cherney; H Loetscher; R G Ridley; M N James
Journal:  Nat Struct Biol       Date:  1999-01

7.  Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

Authors:  E T Baldwin; T N Bhat; S Gulnik; M V Hosur; R C Sowder; R E Cachau; J Collins; A M Silva; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 8.  Structure-based design of β-site APP cleaving enzyme 1 (BACE1) inhibitors for the treatment of Alzheimer's disease.

Authors:  Jing Yuan; Shankar Venkatraman; Yajun Zheng; Brian M McKeever; Lawrence W Dillard; Suresh B Singh
Journal:  J Med Chem       Date:  2013-04-05       Impact factor: 7.446

9.  Polar hydrogen positions in proteins: empirical energy placement and neutron diffraction comparison.

Authors:  A T Brünger; M Karplus
Journal:  Proteins       Date:  1988

10.  Antiretroviral agents and prevention of malaria in HIV-infected Ugandan children.

Authors:  Jane Achan; Abel Kakuru; Gloria Ikilezi; Theodore Ruel; Tamara D Clark; Christian Nsanzabana; Edwin Charlebois; Francesca Aweeka; Grant Dorsey; Philip J Rosenthal; Diane Havlir; Moses R Kamya
Journal:  N Engl J Med       Date:  2012-11-29       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.